Many Americans rely on drugs, medical devices, and surgery at some point in their lives to combat sickness or disease. But despite medical advances, lifespans are shortening, cancer rates are skyrocketing, and rare diseases are becoming more widespread. Simultaneously, cutting-edge medical research is no longer seeking to address these alarming concerns. Instead, “medical science is…
PREMIERING April 14, 10:30 AM ET: Altered Humans—How Biotech Is Changing Who We Are | Documentary
April 13, 2023
admin
Altered HumansbiotechdocumentariesdocumentaryEpoch CinemaEpoch OriginalEpochTVHealth VideosLive VideosVideo
0 Comment
Why Is a CCP-Backed Biotech Firm Operating in Various US Cities?
Commentary President Joe Biden on Sept. 12 launched a new initiative designed to funnel an unspecified amount of cash into the U.S. biotechnology industry. The initiative’s aim is simple: to make the United States more efficient and reduce dependence on communist China in the biotech space. A noble goal, no doubt. However, to beat China, a country that seeks…
Biden’s New Biotech Order
September 16, 2022
admin
bidenBioeconomybiotechBusiness & MarketsBusiness ColumnistsChinaOpinionThinking About ChinaViewpoints
0 Comment
Commentary The Biden administration is boosting biotech. Big time. It’s leveraging $2 billion to turbocharge the bioeconomy in America for a market expected to add tens of trillions of dollars in value over the coming years. “Global industry is on the cusp of an industrial revolution powered by biotechnology,” according to a White House fact…
Record Amount of Fentanyl, Meth Seized in Arizona, Texas
The U.S. fentanyl crisis is being helped along by a Chinese city. President Joe Biden signed an executive order to boost biotechnology. It’s an effort to compete with China, but Beijing is taking action, too. California is banning foreign governments and companies from buying U.S. farmland. Books about sheep and wolves put a group of…
Biden Signs Executive Order to Boost Biotech to Counter China Threat
September 12, 2022
admin
biotechBusiness & Marketseconomic policieseconomyExecutive BranchNational Biotechnology and Biomanufacturing InitiativePolicies & ImpactsPoliticsTechUSUS News
0 Comment
President Joe Biden has signed an executive order meant to boost biotech production and research in the United States, with a senior administration official saying that the presidential action was prompted in part by aggressive investment in the sector by China, posing a risk to U.S. competitiveness. The White House announced on Sept. 12 that…
Young Girl Contracted Myocarditis after Receiving Chinese-German Vaccine; 3 Elderly Also Got Vaccinated Before Death
Earlier in June 2022, an 11-year-old girl in Hong Kong fell ill with myocarditis three weeks after getting vaccinated. She is currently in a stable condition after completing heart surgery. According to the reports which Hong Kong’s Department of Health (DH) received, three elderly citizens had taken the same vaccination within 14 days before they…
Buy the Dips Is Becoming Sell the Rips, yet Good Investment Opportunities Abound
Commentary We have most likely begun a cyclical bear market. Such things used to be fairly commonplace, along with the lesser 10–15 percent or so corrections within broad stock up-trends. Particularly since the start of the pandemic two years ago, the Federal Reserve has all but outlawed such moves with its BIG thumb on the…
CCP Investment in US Biopharm and Genomics Companies Raises Security Concerns
February 7, 2022
admin
AnalysisbiotechChinaChina Business & EconomyOpinionThinking About ChinaThreat from Communist ChinaUS-China relationsViewpoints
0 Comment
News Analysis A growing number of biotech, genomics, and medtech firms with ties to the Chinese Communist Party (CCP) are operating in the United States, raising concerns about medical and genetic data security. With more than $1 trillion at its disposal, China’s sovereign wealth fund has over 33 percent of the world’s total sovereign wealth…
The Week Ahead in Biotech (Jan 31-Feb 5)
The broader market weakness spread into the biotech sector in the week ending Jan. 28, sending stocks lower. Johnson & Johnson got the ball rolling on large-cap biopharma earnings, with mixed results. The positive forward outlook, however, lent support to the stock. Edwards Lifesciences Corporation came under pressure following an earnings miss. Among other noteworthy developments,…
Djokovic and Wife Own 80 Percent Stake in Biotech Company Developing Non-Vaccine COVID-19 Treatment: Report
January 20, 2022
admin
biotechBusiness & EconomyBusinesses in COVID-19CCP VirusCOVID-19DjokovicEuropeInternationalVaccines & SafetyWorld
0 Comment
Tennis star Novak Djokovic and his wife own an 80 percent share in a Danish biotech firm developing a treatment for COVID-19 that does not involve vaccination, the company’s boss said on Wednesday. The Serbian native 34, and his wife Jelena, 35, bought a majority stake in QuantBioRes back in June 2020, just months into the pandemic, the company’s chief…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta